SURGE
LIVE

Serial Number

79358759

Owner

SurgeCare

Attorney

Daniel Lano

Filing Date

Jul 21, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SURGE Trademark

Serial Number: 79358759

SURGE is a trademark filed by SurgeCare on July 21, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

SurgeCare (3 trademarks)

1 rue des Soeurs

Entity Type: 99

Trademark Details

Filing Date

July 21, 2022

Registration Date

Not Registered

Goods & Services

Collection, compilation and systematization of information into computer databases in the field of pharmaceutical research and development, medicine and clinical trials; database management in the field of pharmaceutical research and development, medicine and clinical trials; compilation of statistics for business purposes in the field of health and medicine; collection and systemization of information into computer databases in the field of pharmaceutical, health and medical research and development; public relations in the field of health and medicine

Provision of medical information services; providing medical information; medical services and medical services in the field of surgery; pharmaceutical services, namely, pharmaceutical research services; pharmaceutical consultation; information and advisory services relating to pharmaceutical products, namely pharmaceutical advice and providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; telemedicine services; medical assistance; remote medical assistance; advice in connection with dietetics and nutrition; providing information relating to nutrition; wellness services being health and nutrition counseling; preparation of psychological profiles for medical purposes, namely psychological testing for medical purposes; professional consultancy in the field of medical technology, medical surgery and orthopedics, namely, medical consultation; remote monitoring of medical data for medical diagnosis and treatment purposes; medical and surgical diagnostic services, namely, medical diagnostic testing, monitoring and reporting services; alternative medicine services

Downloadable or recorded artificial intelligence computer programs in the field of medical diagnostics to identify patients at risk of a clinical outcome; downloadable Software as a Medical Device [SaMD] for analyzing medical data to identify patients at risk of a clinical outcome; data processing programs in the medical field, namely, downloadable or recorded programs to identify patients at risk of a clinical outcome; vials for laboratories being laboratory glassware, for collection and/or blood stimulation

Software design and development in the field of pharmaceutical, health and medical research to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; providing information with respect to medical research in the field of pharmaceutical products and medical devices to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; medical and scientific research namely, conducting clinical trials for others relating to pharmaceutical products and medical devices, namely to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; scientific and technological services, namely, scientific research with respect to medicine to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; bio-informatic, chemical and biological analysis to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; scientific research in the fields of chemistry, biology, bacteriology, nutrition, biotechnology to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; product research and development services in the field of immunology to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; Software as a Service [SaaS] in the medical and health fields used to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway

Surgical apparatus and instruments for medical use, namely blood sample kit; Medical apparatus and instruments namely to identify patients at risk of a clinical outcomes, namely blood sample kit; in-vitro diagnostic medical devices, namely medical diagnostic apparatus for testing to identify clinical outcome and/or risk factors for complications during surgery

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 16, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 15, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 13, 2024 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 30, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 7, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 7, 2024 OPNR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 20, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 20, 2024 GNSL
SUSPENSION LETTER WRITTEN
Feb 20, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 26, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 26, 2023 TROA
REFUSAL PROCESSED BY IB
Jul 22, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 23, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 23, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 18, 2023 RFCR
NON-FINAL ACTION WRITTEN
May 17, 2023 CNRT
ASSIGNED TO EXAMINER
May 9, 2023 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 17, 2023 ADCH
APPLICATION FILING RECEIPT MAILED
Jan 7, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 29, 2022 REPR